Comparison of ranibizumab and conbercept treatment in type 1 prethreshold retinopathy of prematurity in zone II
Both conbercept and ranibizumab for treating type 1 prethreshold ROP in Zone II are safe and effective. They had little effect on the development of ocular whereas there was a slight tendency of myopia after the treatment.
Authors
- Zonghua Wang (ORCID: https://orcid.org/0000-0002-0869-9683)
- Qiuping Li (ORCID: https://orcid.org/0000-0002-9607-026X)
- Mou-Nian Zhang
- Xiumei Yang
Institutions
- Chinese General Hospital College of Nursing and Liberal Arts (PH)
- People's Liberation Army No. 150 Hospital (CN)
- Chinese People's Liberation Army (CN)
Publication Details
- Journal
- BMC Pediatrics
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1186/s12887-024-05017-1
- Citations
- 2
- Primary Topic
- Retinopathy of Prematurity Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Chinese People’s Liberation Army